Fulltext

Comment on "A pilot trial of G3139, a bcl-2 antisense oligonucleotide, and paclitaxel in patients with chemorefractory small-cell lung cancer”, by C. M. Rudin et al. (Ann Oncol 2002; 13: 539-545)

Gautschi, O. ; Zangemeister-Wittke, U. ; Stahel, R. A.

In: Annals of Oncology, 2003, vol. 14, no. 1, p. 170-170

Ajouter à la liste personnelle
    Titre
    • Comment on "A pilot trial of G3139, a bcl-2 antisense oligonucleotide, and paclitaxel in patients with chemorefractory small-cell lung cancer”, by C. M. Rudin et al. (Ann Oncol 2002; 13: 539-545)
    Auteur
    • Gautschi, O.. Division of Medical Oncology, University Hospital, Bern
    • Zangemeister-Wittke, U.. Division of Medical Oncology, University Hospital, Zürich, Switzerland
    • Stahel, R. A.. Division of Medical Oncology, University Hospital, Zürich, Switzerland
    Type de document
    • Postprint
    Langue
    • Anglais
    Publié dans
    • Annals of Oncology, 2003, vol. 14, no. 1, p. 170-170. Oxford University Press
    Autre version électronique
    Classification
    • Santé
    Identifiant OAI-PMH
    • oai:doc.rero.ch:297684